Strong Market Position Temedica operates in the growing digital health sector with a focus on real-world data and AI-driven solutions, making it an attractive partner for pharma companies seeking innovative go-to-market strategies.

Recent Funding & Expansion With over €42 million raised in Series B funding and recent product launches like the Dibi app, Temedica demonstrates strong growth potential and resource availability for scaling customized health solutions.

Strategic Collaborations Partnerships with industry leaders such as Bristol Myers Squibb and sponsorship from Novo Nordisk highlight Temedica’s credibility and opportunities for joint development of digital health tools targeting chronic conditions.

Technological Capabilities Leveraging a sophisticated tech stack including AI, data platforms, and mobile apps, Temedica is well-positioned to deliver innovative data analytics and app development solutions for pharma clients looking to enhance patient engagement.

Growth Opportunities With a niche focus on digital health and digital companions for chronic diseases, Temedica offers potential sales opportunities in expanding telehealth, patient support programs, and real-world evidence collection for pharmaceutical companies.